- Send to friend
- Customers Also Bought
- Customer feedback
Stiruba | Ormed
Stiruba, a Microspheres extraction of the herb Simaruba of cinalis, is a powerful anti-parasitic that has proved helpful for some cases of Babesia. Stiruba is used in France by M.D. specialists in phytoaromatherapy for treating fungal infections and several types of parasitic infections including Trichomonas, Babesia and Entamoeba histolytica.
Developed by Iderne pharmaceuticals in France, Microspheres (also called Phytomicrospheres) are made using a special plant ber that acts as a carrier to bring herbal constituents into the blood stream unattenuated. As a result, nothing is lost from the extraction process. The microspheres contain no excipients, and they transport the phytochemicals to the serum without degradation from the digestive tract.
The Microspheres process has been designated an ethical medical modality that will replace the use of tinctures in phytotherapy practice by the European Union. Iderne Pharmaceuticals has produced a number of compounds including one designated as a treatment for diabetes by the European Union
Stiruba | Ormed
Simarouba bark (Simarouba of cinalis)
60 Microspheres capsules
Recommended dose: one capsule twice a day
Dosage can be increased if there is insuf cient response
The leaves and bark of Simarouba (Simarouba of cinalis) have long been used as a natural med- icine in the tropics. Simarouba was rst imported into France from Guyana in 1713 as a remedy for dysentery. When France suffered a dysentery epidemic from 1718 to 1725, simarouba bark was one of the few effective treatments. French explorers “discovered” this effective remedy when they found that the indigenous Indian tribes in the Guyana rainforest used simarouba bark as an effective treatment for malaria and dysentery – much as they still do today. Other indige- nous tribes throughout the South American rainforest use simarouba bark for fevers, malaria, and dysentery, as a hemostatic agent to stop bleeding, and as a tonic.
Simarouba also has a long history in herbal medicine in many other countries. In Cuba, where it is called gavilan, an infusion of the leaves or bark is considered to be astringent, a digestion and menstrual stimulant and an anti-parasitic remedy. It is taken internally for diarrhea, dysen- tery, malaria, and colitis; it is used externally for wounds and sores. In Belize the tree is called negrito or dysentery bark. There the bark (and occasionally the root) is boiled in water to yield a powerful astringent and tonic used to wash skin sores and to treat dysentery, diarrhea, stomach and bowel disorders, hemorrhages, and internal bleeding. In Brazil it is employed much the same way against fever, malaria, diarrhea, dysentery, intestinal parasites, indigestion, and anemia. In Brazilian herbal medicine, simarouba bark tea has long been the most highly recommended (and
most effective) natural remedy against chronic and acute dysentery.
After a 200-year documented history of use for dysentery, simarouba bark’s use for amebic dys- entery was nally validated by conventional doctors in 1918. A military hospital in England demonstrated that the bark tea was an effective treatment for amebic dysentery in humans. The Merck Institute reported that simarouba was 91.8% effective against intestinal amebas in humans in a 1944 study and, in 1962, other researchers found that the seeds of simarouba showed active anti-amebic activities in humans. In the 1990s, scientists again documented simarouba’s ability to kill the most common dysentery-causing organism, Entamoeba histolytica, as well as two di- arrhea-causing bacteria, Salmonella and Shigella.
Scientists rst looked at simarouba’s antimalarial properties in 1947, when they determined a wa- ter extract of the bark (as well as the root) demonstrated strong activity against malaria in chick- ens. This study showed that doses of only 1 mg of bark extract per kg of body weight exhibited strong antimalarial activity. When new strains of malaria with resistance to the existing antima- larial drugs began to develop, scientists began studying simarouba once again. Studies published between 1988 and 1997 demonstrated that simarouba and/or its three potent quassinoids were ef- fective against malaria in vivo as well as in vitro. More importantly, the research indicated that the plant and its chemicals were effective against the new drug-resistant strains in vivo and in vitro
Disclaimer: The statements enclosed herein have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease
Since we do not know everything about your medical history and medications, please consult with your health care practitioner before implementing any new protocols and supplements. Do not construe any information listed on this site as a substitute for actual medical advice. The info you receive from us is not intended to replace medical advice by your doctor. Forrest Health, Inc. does not dispense medical advice, prescribe, or diagnose illness. We offer nutritional programs and supplements that support your health. The views and nutritional advice expressed by Forrest Health, Inc. are not intended to be a substitute for conventional medical service. If you have a medical condition, see your physician of choice